Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Net Cash Flow (2023 - 2025)

Incannex Healthcare's Net Cash Flow history spans 3 years, with the latest figure at -$3.7 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 143.54% year-over-year to -$3.7 million; the TTM value through Dec 2025 reached $67.0 million, up 667.02%, while the annual FY2025 figure was $8.9 million, 155.13% up from the prior year.
  • Net Cash Flow for Q4 2025 was -$3.7 million at Incannex Healthcare, down from $58.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $58.0 million in Q3 2025 and bottomed at -$6.0 million in Q3 2023.
  • The 3-year median for Net Cash Flow is -$2.2 million (2023), against an average of $4.7 million.
  • The largest YoY upside for Net Cash Flow was 2623.81% in 2025 against a maximum downside of 143.54% in 2025.
  • A 3-year view of Net Cash Flow shows it stood at -$2.2 million in 2023, then rose by 29.46% to -$1.5 million in 2024, then tumbled by 143.54% to -$3.7 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Net Cash Flow are -$3.7 million (Q4 2025), $58.0 million (Q3 2025), and $8.1 million (Q2 2025).